Anti-Mouse MAdCAM-1 (MECA-89) – Purified in vivo PLATINUMTM Functional Grade

Anti-Mouse MAdCAM-1 (MECA-89) – Purified in vivo PLATINUMTM Functional Grade

Product No.: M1421

[product_table name="All Top" skus="M1400"]

- -
- -
Clone
MECA-89
Target
MADCAM-1
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
Mucosal addressin cell adhesion molecule-1
Isotype
Rat IgG2a κ
Applications
B
,
FA
,
FC
,
IF
,
IHC
,
IP
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Rat
Recommended Isotype Controls
Recommended Isotype Controls
Recommended Dilution Buffer
Immunogen
Mouse mesenteric and peripheral lymph node cells
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
≤ 1.0 EU/mg as determined by the LAL method
Purity
≥95% by SDS Page
≥95% monomer by analytical SEC
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM<sup>TM</sup> antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2 - 8°C Wet Ice
Additional Applications Reported In Literature ?
FA
IHC
IF
IP
WB
FC
B
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
MECA-89 activity is directed against mouse MAdCAM-1.
Background
MAdCAM-1 is a cell adhesion leukocyte receptor expressed by mucosal venules that helps direct lymphocyte traffic into mucosal tissues and regulates the passage and retention of leukocytes1, 2. MAdCAM-1 binds integrin receptor α4β7 and L-selectin2, 3, 4. Two alternatively spliced isoforms of MAdCAM-1 exist5, both of which are capable of binding α4β72.

MECA-89 was generated by immunizing Wistar rats with endothelial cells isolated from BALB/c mesenteric and peripheral lymph nodes 6. Immunohistological screening of hybridomas yielded two mAbs, MECA-367 and MECA-89, that stain high endothelial venules (HEVs) in mucosal lymphoid organs and Peyer’s patches, but not peripheral lymph nodes (axillary, brachial, popliteal, and inguinal). Immunofluorescence staining of high endothelial cells shows that both MECA-367 and MECA-89 react with antigens on the cell surface. The epitopes for MECA-367 and MECA-89 are distinct. MECA-367 recognizes the N-terminal immunoglobulin domain of MAdCAM-l, and MECA-89 recognizes the second immunoglobulin domain 4,5.

MECA-89 reacts with the same vessels as MECA-367 and binds to isolated MECA-367 antigen; however, unlike MECA-367 it has no effect on lymphocyte binding 6. Additionally, MECA-89 has no effect on MAdCAM-1 binding to α4β7 in vitro 7, but L-selectin dependent adhesion is lost in the presence of MECA-89 4. Additionally, MECA-89 has no significant effect on activated cells, but all interactions are inhibited following subsequent injection of anti-α4 Fab fragments 4. In vivo, MECA-89 inhibits L-selectin-dependent rolling but not direct α4β7-dependent attachment of Mn2+ activated lymphocytes.
Antigen Distribution
MAdCAM-1 is a cell surface glycoprotein selectively expressed on high endothelial venules of mucosal lymphoid organs and Peyer’s patches as well as lamina propria venules.
Ligand/Receptor
Integrin a4ß7, CD62L
NCBI Gene Bank ID
UniProt.org
Research Area
Cell Adhesion
.
Cell Biology
.
Immunology

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Clone MECA-89 is used in in vivo mouse studies primarily for targeting MAdCAM-1 (Mucosal Vascular Addressin Cell Adhesion Molecule 1). MAdCAM-1 is a molecule expressed on the surface of endothelial cells in mucosal venules and is involved in homing of lymphocytes to mucosal tissues. The MECA-89 antibody clone is specifically designed to recognize and bind to this molecule.

Use in Research

  1. Immune Response Studies: By blocking MAdCAM-1, researchers can study the role of this molecule in immune responses, particularly in the migration of lymphocytes to mucosal tissues.
  2. Inflammation and Disease Models: MECA-89 is used to manipulate inflammation and study disease models where MAdCAM-1 plays a critical role, such as in gastrointestinal diseases.
  3. Targeting Specific Tissues: The specificity of MECA-89 for MAdCAM-1 makes it useful for delivering therapeutic agents or studying the effects of blocking lymphocyte homing in specific tissues.

Characteristics of MECA-89

  • Isotype: Rat IgG2a kappa
  • Host: Rat
  • Species Reactivity: Mouse
  • Purity and Endotoxin Levels: High purity (>95%) and low endotoxin levels (<1.0 EU/mg), making it suitable for in vivo studies where minimizing immune responses to the antibody itself is crucial.

Overall, the MECA-89 clone is a valuable tool for studying the role of MAdCAM-1 in immune responses and disease models in mice.

Recommended Storage Temperature for Sterile Packaged Clone MECA-89

Short-term Storage (?1 month):
Sterile packaged clone MECA-89 antibody (Anti-MAdCAM-1, MECA-89) should be stored at 2–8°C when kept sterile in its original packaging. This temperature range is suitable for maintaining stability for up to one month without significant loss of activity. Always keep the packaging closed and sterile to prevent contamination.

Long-term Storage (>1 month):
For extended storage, aseptically aliquot the antibody into working volumes (without dilution) and freeze at ?–70°C (ideally in a suitable ultra-low freezer). For convenience, –20°C is also acceptable for long-term storage, especially if ultra-low freezers are not available, provided the antibody is protected with glycerol or similar cryoprotectants to prevent repeated freeze-thaw damage—avoiding repeated freeze-thaw cycles is critical for preserving antibody integrity.

Summary Table

Storage TypeTemperatureDurationNotes
Short-term2–8°CUp to 1 week, 1 monthKeep sterile, original packaging
Long-term–20°CNot specified, longerAseptic aliquots, avoid freeze-thaw
Optimal long-term?–70°CNot specified, longerAseptic aliquots, ideal stability

Additional Recommendations

  • Aseptic Handling: Always aliquot under sterile conditions to prevent contamination.
  • Avoid Repeated Freeze-Thaw: Freeze in working volumes to minimize freeze-thaw cycles.
  • Manufacturer Guidelines: Always check the specific lot datasheet for any updated storage instructions, as protocols may change.
  • Application Note: The optimal working dilution should be determined empirically for each application.

In summary:
Store sterile packaged clone MECA-89 at 2–8°C for short-term use (up to one month). For long-term storage, aliquot and freeze at ?–70°C (or –20°C if necessary), avoiding repeated freeze-thaw cycles. Always handle aseptically and consult the manufacturer’s datasheet for lot-specific guidance.

Based on the available information, MECA-89 is primarily used as an anti-MAdCAM-1 (Mucosal vascular addressin cell adhesion molecule-1) antibody in research applications. While the search results don't provide extensive details about other antibodies commonly used alongside MECA-89, there are several key reagents and controls that are typically employed with this antibody.

Control Antibodies and Reagents

The most commonly mentioned companion reagent is the Purified Rat IgG2a ? Isotype Control (Cat. No. 559073), which serves as the recommended isotype control for MECA-89 in immunohistochemistry applications. This control is essential for validating the specificity of MECA-89 staining and ensuring that observed binding is antigen-specific rather than due to non-specific interactions.

Detection and Amplification Systems

For immunohistochemical applications, MECA-89 is frequently used with a three-step detection system that includes:

  • Biotin Goat Anti-Rat Ig (Cat. No. 559286) as the secondary antibody
  • Streptavidin-HRP (Cat. No. 550946) for signal amplification
  • DAB detection system (Cat. No. 550880) for visualization

Alternative Conjugated Forms

MECA-89 is also available in conjugated formats, including a biotin-conjugated version (Cat. No. 553808) for flow cytometric applications. This provides researchers with flexibility in their experimental design and detection methods.

Application-Specific Considerations

The antibody is routinely tested for flow cytometry applications and has been validated for immunohistochemistry on acetone-fixed frozen sections. It's particularly effective for staining mucosal lymphoid tissue, lamina propria, and splenic sinus lining cells in mouse tissues, making it valuable for studies investigating mucosal immunity and lymphocyte homing mechanisms.

The search results indicate that MECA-89 requires specific tissue preparation methods, as it's not recommended for formalin-fixed paraffin-embedded sections, which may influence the choice of complementary reagents and protocols used in conjunction with this antibody.

Key findings from scientific literature citing clone MECA-89 focus on the mecA gene’s role and clonal dissemination among methicillin-resistant Staphylococcus aureus (MRSA), mapping its genetic context, and its association with antimicrobial resistance.

  • Clonal dissemination and lineage tracking: Studies have used both pulsed-field gel electrophoresis (PFGE) and ribotyping to track mecA dissemination across S. aureus lineages globally. Over 60% of mecA+ isolates belong to type I lineages, which include notable pandemic MRSA clones (e.g., Brazilian, North German, Hannover, Iberian, Portuguese). Many mecA^?^ methicillin-susceptible S. aureus (MSSA) clones have mecA^+^ MRSA counterparts that differ by a single PFGE band shift, signifying acquisition of the mecA-containing element, often through SCCmec. This genetic switch has been directly observed and mapped in multiple international outbreaks.

  • Genetic structure and resistance determinants: Complete cloning and sequencing of the mecA region revealed that its surrounding genetic cassette (the SCCmec) contains more than 100 open reading frames (ORFs), with several associated with resistance to various antibiotics (including erythromycin, spectinomycin, kanamycin, and bleomycin). The mecA gene encodes PBP2’ and exhibits sequence identity across S. aureus and S. epidermidis, supporting the concept of horizontal gene transfer between staphylococcal species.

  • Prevalence in clinical isolates: In clinical staphylococcal isolates (notably, coagulase-negative staphylococci in neonatal septicemia), the mecA gene carriage is high, often likely due to strong antibiotic selection pressures.

In summary, clone MECA-89 citations have advanced the understanding of MRSA’s global spread, the genetic mobility of mecA, and how resistance determinants integrate into widely distributed pandemic clones, shaping public health responses to staphylococcal infections.

References & Citations

1. https://www.uniprot.org/uniprotkb/Q61826/entry
2. Schiffer SG, Day E, Latanision SM, et al. Biochem Biophys Res Commun. 216(1):170-176. 1995.
3. Berlin C, Berg EL, Briskin MJ, et al. Cell. 74(1):185-195. 1993.
4. Bargatze RF, Jutila MA, Butcher EC. Immunity. 3(1):99-108. 1995.
5. Briskin MJ, McEvoy LM, Butcher EC. Nature. 363(6428):461-464. 1993.
6. Streeter PR, Berg EL, Rouse BT, et al. Nature. 331(6151):41-46. 1988.
7. Nakache M, Berg EL, Streeter PR, et al. Nature. 337(6203):179-181. 1989.
B
FA
Flow Cytometry
IF
IHC
Immunoprecipitation Protocol
General Western Blot Protocol

Certificate of Analysis

- -
- -

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.